Fridays vs Maximus: Compare GLP-1 Programs & Pricing
Side-by-side Fridays and Maximus: semaglutide/tirzepatide starting prices, promos, membership rules, and official links.
Fridays and Maximus are two established telehealth providers offering GLP-1–based weight management programs. This article compares Fridays vs Maximus to help you identify which best fits your goals and preferences. Both companies operate under U.S. FDA‑compliant telehealth regulations and employ licensed clinicians to evaluate eligibility, prescribe medication, and monitor safety.
Fridays vs Maximus: Quick Overview
| Provider | Semaglutide | Tirzepatide | Promo | Membership |
|---|---|---|---|---|
| Fridays | $199.00 | $299.00 | $50 off first month (Code: Live50) | — No |
| Maximus | $132.99 | — No |
Fridays vs Maximus: Medical Process & Accessibility
Fridays utilizes a streamlined intake questionnaire, followed by a virtual visit with a board‑certified endocrinologist or weight‑loss specialist. Once eligibility is confirmed, the clinician issues a prescription that is filled by a U.S.‑based compounding pharmacy. The entire onboarding can be completed within 48 hours for most patients.
Maximus takes a slightly more structured approach. After the initial questionnaire, a licensed physician reviews the case, schedules a tele‑consultation, and creates a personalized dose‑titration plan. Follow‑up appointments are built into the program, allowing clinicians to adjust dosing based on weight loss progress and tolerability.
Fridays vs Maximus: Pricing Comparison
Fridays starts semaglutide at $199.00 and tirzepatide at $299.00 per month. In addition, new patients receive $50 off the first month when they enter the promo code Live50 at checkout. There are no mandatory membership fees, making the cost structure transparent and easy to predict.
Maximus currently lists tirzepatide at $132.99 per month. No semaglutide price is publicly advertised at this time, suggesting it may be offered on a case‑by‑case basis or not part of the standard catalog. Maximus also does not require a membership fee, and while no specific promo is advertised, occasional seasonal discounts may appear on the site.
Fridays vs Maximus: Clinical Oversight & Support
Both platforms provide direct access to licensed clinicians who are authorized to prescribe GLP‑1 therapies. Fridays emphasizes rapid prescription turnaround, often within a single virtual visit, which appeals to users eager to start treatment quickly. Maximus, on the other hand, integrates scheduled follow‑ups, enabling clinicians to monitor blood pressure, glucose, and potential side effects more closely.
Book a Consultation with Fridays
Maximus also offers a patient portal where users can message their care team, view lab results, and track weight‑loss milestones. This level of ongoing interaction can be particularly valuable for individuals who prefer a more hands‑on medical relationship.
Fridays vs Maximus: Medication Quality & Safety
Both companies dispense compounded GLP‑1 medications from FDA‑registered compounding pharmacies located in the United States. The compounds contain the same active ingredients as the brand‑name products Wegovy® (semaglutide) and Mounjaro® (tirzepatide) but are produced at a lower cost under strict quality‑control standards. All prescriptions require a clinician’s order and are subject to the same safety monitoring protocols mandated by federal law.
Fridays vs Maximus: Customer Experience
Patient reviews highlight that Fridays shines in affordability and speed of service. Users often note that the enrollment process can be completed in under an hour, and shipping typically arrives within 5‑7 business days after approval. The platform’s sleek mobile app also allows for easy dose tracking.
Conversely, Maximus receives praise for its thorough clinical support and proactive communication. Patients appreciate the regular check‑ins, detailed educational resources, and the ability to discuss side‑effect management directly with their prescribing physician.
Fridays vs Maximus: Final Verdict
If your primary goal is to start a GLP‑1 therapy quickly while keeping monthly costs low, Fridays is likely the better fit. The clear pricing, $50 first‑month discount, and lack of membership fees make it an attractive option for budget‑conscious consumers.
For individuals who value structured medical oversight, frequent clinician interaction, and a robust support portal, Maximus may provide the more comprehensive experience, especially given its lower tirzepatide price point of $132.99 per month.
Disclaimer
This article is for informational purposes only and does not constitute medical advice. ExploreProviders may receive affiliate commissions at no cost to you. Always consult a licensed clinician before beginning any medical treatment.
Starts at $146/mo (6‑month plan)
- Affordable Semaglutide injections
- Klarna / AfterPay / Affirm supported
- Personalized dosing to reach goals
From $179 + free FedEx
- Approval within ~4 hours*
- Semaglutide & Tirzepatide available
- Price‑lock: same price any dose
Free consult ($75 value)
- GLP‑1 ID Protocol — 46% faster*
- 4.9★ Google & Trustpilot
- No‑obligation evaluation
$120 OFF First Month
- GLP‑1 meds delivered to your door
- Refund if you don’t lose weight
- Doctor‑approved, U.S. clinicians
Save $70 (Code: Explore)
- Ozempic®, Tirzepatide & Semaglutide
- Instant approval, ship ≤ 3 days
- No membership fees
From $155/mo (12‑month plan)
- No insurance or membership required
- Quick approval — no waitlist
- Brand & compounded available
$50 Off First Month
- 2‑minute quiz, $50 off month one
- Prescription in ≤ 24 hours
- Cancel or change anytime
Pay $199 first month
- Free overnight shipping
- Avg. 14% weight loss*
- No insurance needed
$120 OFF First Month
- Affordable access to treatments
- Doctor‑supervised programs
- Clear pricing
$50 OFF First Month
- Streamlined treatment process
- Holistic program
- Mobile‑friendly platform
Programs available
- 100% online evaluation
- Provider messaging & check‑ins
- Fast‑track programs
From $249 / month
- Certified GLP‑1 providers
- Licensed consultations
- Nationwide coverage